Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

2.

The role of colesevelam hydrochloride in hypercholesterolemia and type 2 diabetes mellitus.

Brunetti L, Hermes-Desantis ER.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1196-206. doi: 10.1345/aph.1M728. Epub 2010 Jun 15. Review.

PMID:
20551301
3.

Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol.

Corsini A, Windler E, Farnier M.

Eur J Cardiovasc Prev Rehabil. 2009 Feb;16(1):1-9. doi: 10.1097/HJR.0b013e32831215db. Review.

PMID:
19237992
4.

A review of bile acid sequestrants: potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitus.

Staels B.

Postgrad Med. 2009 May;121(3 Suppl 1):25-30. doi: 10.3810/pgm.2009.05.suppl53.290. Review.

PMID:
19494475
5.

The use of colesevelam hydrochloride in the treatment of dyslipidemia: a review.

Davidson MH.

Expert Opin Pharmacother. 2007 Oct;8(15):2569-78. Review.

PMID:
17931091
6.

Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.

Bays HE, Goldberg RB, Truitt KE, Jones MR.

Arch Intern Med. 2008 Oct 13;168(18):1975-83. doi: 10.1001/archinte.168.18.1975.

PMID:
18852398
7.
8.

Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.

Bays HE, Davidson M, Jones MR, Abby SL.

Am J Cardiol. 2006 Apr 15;97(8):1198-205. Epub 2006 Mar 3. Erratum in: Am J Cardiol. 2006 Aug 1;98(3):428.

PMID:
16616026
9.

A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.

Davidson MH, Donovan JM, Misir S, Jones MR.

Am J Cardiovasc Drugs. 2010;10(5):305-14. doi: 10.2165/11584310-000000000-00000.

PMID:
20860413
10.

Colesevelam hydrochloride.

Steinmetz KL.

Am J Health Syst Pharm. 2002 May 15;59(10):932-9. Review.

PMID:
12040732
11.

Review of studies on the effect of bile acid sequestrants in patients with type 2 diabetes mellitus.

Levy P.

Metab Syndr Relat Disord. 2010 Dec;8 Suppl 1:S9-13. doi: 10.1089/met.2010.0087. Epub 2010 Oct 14. Review.

PMID:
20946010
12.
13.
14.

Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects.

Davidson MH, Dillon MA, Gordon B, Jones P, Samuels J, Weiss S, Isaacsohn J, Toth P, Burke SK.

Arch Intern Med. 1999 Sep 13;159(16):1893-900.

PMID:
10493319
15.

Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.

Jones MR, Mudaliar S, Hernandez-Triana E, Unnikrishnan AG, Lai YL, Abby SL, Misir S, Jin X, Nagendran S.

Curr Med Res Opin. 2009 Sep;25(9):2239-49. doi: 10.1185/03007990903126791.

PMID:
19622007
16.

Evaluation of colesevelam hydrochloride for the treatment of type 2 diabetes.

Younk LM, Davis SN.

Expert Opin Drug Metab Toxicol. 2012 Apr;8(4):515-25. doi: 10.1517/17425255.2012.672973. Review.

PMID:
22432790
17.

Colesevelam.

Melian EB, Plosker GL.

Am J Cardiovasc Drugs. 2001;1(2):141-6; discussion 147-8. Review.

PMID:
14728043
18.

Colesevelam hydrochloride: a non-absorbed, polymeric cholesterol-lowering agent.

Davidson MH, Dicklin MR, Maki KC, Kleinpell RM.

Expert Opin Investig Drugs. 2000 Nov;9(11):2663-71. Review.

PMID:
11060828
19.

Expanded colesevelam administration options with oral suspension formulation for patients with diabetes and hypercholesterolemia.

Dayer-Berenson L, Finckenor M.

Postgrad Med. 2014 May;126(3):126-34. doi: 10.3810/pgm.2014.05.2762. Review.

PMID:
24918798
20.

The role of colesevelam HCl in type 2 diabetes mellitus therapy.

Handelsman Y.

Postgrad Med. 2009 May;121(3 Suppl 1):19-24. doi: 10.3810/pgm.2009.05.suppl53.289. Review.

PMID:
19494474

Supplemental Content

Support Center